drugset / Trial / NCT03678090
The Safety and Efficacy of Fibrinolysis in Patients With an Indwelling Pleural Catheter for Multi-loculated Malignant Pleural Effusion.
RandomizedParallel-groupDouble-blindTreatment
Summary
The safety and efficacy of fibrinolysis in patients with an indwelling pleural catheter for multi-loculated malignant pleural effusion.
Timeline
- Start
- 2018-12-01
- Primary completion
- 2020-02-28
- Completion
- 2020-02-28
Outcome
Outcome not reported
Stopped: “Local IRB recommended IND exemption from FDA, study timeline not able to be met.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | tPA | Unknown | 2.5 mg | — |
| Comparator | tPA | Unknown | 25 mg | — |